Your browser doesn't support javascript.
loading
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies.
Huang, Shengkang; Wang, Xinyu; Wang, Yu; Wang, Yajing; Fang, Chenglong; Wang, Yazhuo; Chen, Sifei; Chen, Runkai; Lei, Tao; Zhang, Yuchen; Xu, Xinjie; Li, Yuhua.
Afiliação
  • Huang S; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wang X; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang Y; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wang Y; The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Fang C; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wang Y; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Chen S; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Chen R; School of Rehabilitation Sciences, Southern Medical University, Guangzhou, China.
  • Lei T; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang Y; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xu X; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Li Y; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Mol Cancer ; 22(1): 80, 2023 05 06.
Article em En | MEDLINE | ID: mdl-37149643

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China